Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate ...

A breakthrough in cancer treatment has emerged from a multi-institutional study led by the Moffitt Cancer Center in Florida, ...

A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic ...

Pulse Biosciences is developing nsPFA technology for cardiac ablation to treat AFib and for ablating benign thyroid nodules.

A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may help patients with a rare eye cancer that has spread to ...

which is isolated with a series of catheters and balloons via percutaneous insertions. The chemotherapy is filtered out before it gets introduced to the rest of the body. This targeted approach helps ...

Yourbiology is a company that makes dietary supplements. Its product, called Gut+, can help relieve symptoms of Constipation ...

Boston Scientific Corporation ( NYSE: BSX) Q1 2025 Results Conference Call April 23, 2025 8:00 AM ET Jon Monson - Senior Vice President, Investor Relations Mike Mahoney - Chairman and Chief Executive ...

“Another one of my cousins, he’s getting a port now,” Mark said, referring to the under-skin catheters used in ... some indication of AFFF’s toxic effects decades before such information ...

This excerpt comes from the forthcoming book “Poisoning the Well: How Forever Chemicals Contaminated America,” which details how a set of toxic compounds have devastated entire communities across the ...